US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 30.740
- +0.590+1.96%
Close Nov 21 16:00 ET
- 31.500
- +0.760+2.47%
Post 19:09 ET
2.02BMarket Cap-15845P/E (TTM)
32.380High30.335Low1.88MVolume30.710Open30.150Pre Close59.00MTurnover2.89%Turnover RatioLossP/E (Static)65.68MShares53.69052wk High8.49P/B2.00BFloat Cap18.45052wk Low--Dividend TTM65.12MShs Float302.500Historical High--Div YieldTTM6.78%Amplitude2.140Historical Low31.357Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Tandem Diabetes Care Stock Forum
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S (NVO.US)$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $Eli Lilly and Co (LLY.US)$ , whic...
No comment yet